Jump to page content

Mission

CLIC’s mission is to provide the tools, expertise, and collaborative space needed to drive the next generation of personalized medical solutions, particularly in APTs. By combining scientific rigor with entrepreneurial guidance, CLIC ensures that academic researchers, clinicians, and startup founders can transform promising innovations into therapies that have a tangible impact on patient care.

Who It Serves

CLIC is designed to serve entrepreneurs, early-stage startups, and academic research teams that are focused on pioneering new therapies. Whether it's startups developing cutting-edge biomedical technologies or researchers looking to advance their clinical studies, CLIC provides the infrastructure, mentorship, and regulatory support necessary for success. It is particularly suited for those working in regenerative medicine, oncology, and rare diseases, offering tailored services to help these teams navigate the complexities of clinical development.

Key Offerings

Partnership with BioLabs

At the heart of CLIC’s offering is its collaboration with BioLabs, a global leader in life science incubator management. This partnership empowers CLIC to deliver best-in-class infrastructure and services, drawing on BioLabs’ extensive experience in supporting life science startups around the world. Through this partnership, CLIC taps into BioLabs' international network, providing startups with unparalleled access to resources, expertise, and capital.

BioLabs brings a proven track record of fostering successful biotech companies, having supported over 55 startups in Europe in just in the first year of operation and helping them raise more than €6.5 billion since its founding. By leveraging this global network, CLIC ensures that entrepreneurs in Berlin benefit from a fertile environment for growth and innovation.

Team

Steering Committee

Dr. Johannes Fruehauf, Dr. Andreas Hüser, Dr. Georg Duda, and Dr. Ludovic Vallier serve on the BIH Clinical Incubator's Steering Committee. They provide strategic guidance to ensure alignment with the incubator’s mission and translational goals. The committee reviews incubator focus areas, intake processes, and overall program development. It also supports integration with clinical departments and research units, and brings external perspectives on innovation, regulation, and emerging trends in advanced therapies.